Fuadelhibri.ws

• Feeds

  • Entries (RSS)
  • Comments (RSS)

• You are currently browsing the archives for the Uncategorized category.

• Archives

  • April 2012
  • March 2012
  • February 2012
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • January 2010
  • December 2009
  • October 2009
  • August 2009
  • July 2009

• Categories

  • Abdul Aziz Said (1)
  • American Society of Hematology (1)
  • Anthrax (6)
  • Arab (2)
  • BacilleCalmette-Guerin (1)
  • BioDefense (2)
  • biotech (1)
  • Biothrax (10)
  • Board of directors (2)
  • Business (5)
  • Chief executive officer (51)
  • Chief financial officer (1)
  • Chief Medical Officer (1)
  • Chief operating officer (1)
  • Clinical Research (1)
  • Clinical trial (2)
  • colleagues (1)
  • Dr. Mary Elizabeth King (1)
  • El-Hibri (5)
  • El-Hibri Peace Education Prize (5)
  • Emergent BioSolutions (55)
  • Entrepreneur (3)
  • Ernst & Young (1)
  • Financial Performance (1)
  • Financial Results (2)
  • Food and Drug Administration (11)
  • Foundation (2)
  • fuad el-hibri (56)
  • fuad profiles (1)
  • Health Care (5)
  • Healthcare Conference (4)
  • Infectious disease (4)
  • Investor relations (1)
  • Investors (5)
  • Lymphocytic Leukemia (1)
  • Maryland (2)
  • Music (1)
  • National Health Museum (1)
  • NATO (1)
  • Non-Hodgkin lymphoma (1)
  • North Atlantic Treaty Organization (1)
  • NuThrax (1)
  • Peace Education (3)
  • Pharmaceuticals (2)
  • Resource Center (1)
  • Revenue (1)
  • Scholars Program (1)
  • Seattle (1)
  • Share (1)
  • Shareholder (4)
  • South Africa (1)
  • TB Vaccine (1)
  • Tech Council of Maryland (1)
  • Trubion Pharmaceuticals (3)
  • Tuberculosis (2)
  • U.S. Food and Drug Administration (18)
  • Uncategorized (9)
  • United States Department of Defense (1)
  • United States Department of Health and Human Services (2)
  • Vaccine (6)
  • Washington (3)
  • Yale University (4)

Archives

Uncategorized

Select Month April 2012  (1) March 2012  (1) February 2012  (2) November 2011  (1) October 2011  (3) September 2011  (2) August 2011  (2) July 2011  (2) June 2011  (4) May 2011  (2) April 2011  (3) March 2011  (2) February 2011  (2) January 2011  (2) December 2010  (2) November 2010  (2) October 2010  (2) September 2010  (2) August 2010  (4) July 2010  (5) June 2010  (2) May 2010  (2) April 2010  (1) March 2010  (2) January 2010  (1) December 2009  (3) October 2009  (2) August 2009  (2) July 2009  (8) Select Category Abdul Aziz Said  (1) American Society of Hematology  (1) Anthrax  (6) Arab  (2) BacilleCalmette-Guerin  (1) BioDefense  (2) biotech  (1) Biothrax  (10) Board of directors  (2) Business  (5) Chief executive officer  (51) Chief financial officer  (1) Chief Medical Officer  (1) Chief operating officer  (1) Clinical Research  (1) Clinical trial  (2) colleagues  (1) Dr. Mary Elizabeth King  (1) El-Hibri  (5) El-Hibri Peace Education Prize  (5) Emergent BioSolutions  (55) Entrepreneur  (3) Ernst & Young  (1) Financial Performance  (1) Financial Results  (2) Food and Drug Administration  (11) Foundation  (2) fuad el-hibri  (56) fuad profiles  (1) Health Care  (5) Healthcare Conference  (4) Infectious disease  (4) Investor relations  (1) Investors  (5) Lymphocytic Leukemia  (1) Maryland  (2) Music  (1) National Health Museum  (1) NATO  (1) Non-Hodgkin lymphoma  (1) North Atlantic Treaty Organization  (1) NuThrax  (1) Peace Education  (3) Pharmaceuticals  (2) Resource Center  (1) Revenue  (1) Scholars Program  (1) Seattle  (1) Share  (1) Shareholder  (4) South Africa  (1) TB Vaccine  (1) Tech Council of Maryland  (1) Trubion Pharmaceuticals  (3) Tuberculosis  (2) U.S. Food and Drug Administration  (18) Uncategorized  (9) United States Department of Defense  (1) United States Department of Health and Human Services  (2) Vaccine  (6) Washington  (3) Yale University  (4) Browse All

• Nominations Being Accepted Now for 2010 El-Hibri Peace Education Prize ( March 12, 2010)
• Fuad El-Hibri on Forbes ( July 15, 2009)
• Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Finalist in Greater Washington ( July 15, 2009)
• Fuad El-Hibri Profiles ( July 15, 2009)
• Corporate Governance – Biography Fuad El-Habri ( July 15, 2009)
• U.S. Government To Purchase Additional 14.5 Million Doses Of Biothrax® Under New Contract Valued At Up To $404 Million ( July 13, 2009)
• Emergent Biosolutions Acquires Monoclonal Anthrax Product Candidate ( July 13, 2009)
• Emergent Biosolutions Submits Proposal In Response To Hhs’ Rfp For Development And Procurement Of A Recombinant Protective Antigen Anthrax Vaccine ( July 13, 2009)
• Emergent Biosolutions Acquires Advanced Recombinant Protective Antigen Anthrax Vaccine Candidate And Technology ( July 13, 2009)